Émilie Durieu

1.2k citations

26 papers · 874 indexed · h-index 18

Co-authors: Laurent Meijer Jean Pierre Bazureau François Carreaux Olivier Lozach Tania Tahtouh Stefan Knapp P. Filippakopoulos M. Soundararajan
Topics: Synthesis and biological activity (6 papers)Synthesis and Characterization of Heterocyclic Compounds (3 papers)Microbial Natural Products and Biosynthesis (3 papers)
Cited by: Organic Chemistry Toxicology Biotechnology
Journals: Clinical Cancer Research The FASEB Journal Journal of Medicinal Chemistry
Partner nations: France United Kingdom United States

In The Last Decade

Émilie Durieu

26 papers receiving 850 citations

Peers

Countries citing papers authored by Émilie Durieu

Since Specialization

Citations

This map shows the geographic impact of Émilie Durieu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Émilie Durieu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Émilie Durieu more than expected).

Fields of papers citing papers by Émilie Durieu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Émilie Durieu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Émilie Durieu. The network helps show where Émilie Durieu may publish in the future.

Co-authorship network of co-authors of Émilie Durieu

This figure shows the co-authorship network connecting the top 25 collaborators of Émilie Durieu. A scholar is included among the top collaborators of Émilie Durieu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Émilie Durieu. Émilie Durieu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Role of ICAM-1 in the Adhesion of T Cells to Enteric Glia: Perspectives in the Formation of Plexitis in Crohn’s Disease 2024 ·Cellular and Molecular Gastroenterology and Hepatology ·(unknown),Tony Durand,Catherine Le Berre,Rhiannon T. Filippone,(unknown),Émilie Durieu,Céline Bossard,Sarah Bruneau,Malvyne Rolli‐Derkinderen,Kulmira Nurgali,Michel Neunlist,Arnaud Bourreille,Isabelle Neveu,Philippe Naveilhan	6
2	Intestinal Epithelial AMPK Deficiency Causes Delayed Colonic Epithelial Repair in DSS-Induced Colitis 2022 ·Cells ·(unknown),(unknown),(unknown),(unknown),Émilie Durieu,Marc Foretz,Michel Neunlist,Malvyne Rolli‐Derkinderen,Benoı̂t Viollet	28
3	Design and Microwave Synthesis of New (5Z) 5-Arylidene-2-thioxo-1,3-thiazolinidin-4-one and (5Z) 2-Amino-5-arylidene-1,3-thiazol-4(5H)-one as New Inhibitors of Protein Kinase DYRK1A 2021 ·Pharmaceuticals ·Khadidja Bourahla,Solène Guihéneuf,Emmanuelle Limanton,Ludovic Paquin,Rémy Le Guével,Thierry D. Charlier,Mustapha Rahmouni,Émilie Durieu,Olivier Lozach,François Carreaux,Laurent Meijer,Jean Pierre Bazureau	11
4	Tau accumulates in Crohn's disease gut 2020 ·The FASEB Journal ·Alice Prigent,Guillaume Chapelet,(unknown),Thibauld Oullier,Émilie Durieu,Arnaud Bourreille,Émilie Duchalais,Kévin Hardonnière,Michel Neunlist,Wendy Noble,Saadia Kerdine‐Römer,Pascal Derkinderen,Malvyne Rolli‐Derkinderen	20
5	A Collection of Bioactive Nitrogen-Containing Molecules from the Marine Sponge Acanthostrongylophora ingens 2019 ·Marine Drugs ·Germana Esposito,(unknown),Arlette Longeon,Alfonso Mangoni,Émilie Durieu,Laurent Meijer,Rob W. M. van Soest,Valeria Costantino,Marie‐Lise Bourguet‐Kondracki	7
6	Characterisation of tau in the human and rodent enteric nervous system under physiological conditions and in tauopathy 2018 ·Acta Neuropathologica Communications ·(unknown),(unknown),Anne-Gaëlle Corbillé,Alice Prigent,Sébastien Paillusson,(unknown),Jacques Gonzalès,Émilie Durieu,Malvyne Rolli‐Derkinderen,Emmanuel Coron,Émilie Duchalais,Michel Neunlist,Michael S. Perkinton,Diane P. Hanger,Wendy Noble,Pascal Derkinderen	36
7	Marine-Derived 2-Aminoimidazolone Alkaloids. Leucettamine B-Related Polyandrocarpamines Inhibit Mammalian and Protozoan DYRK & CLK Kinases 2017 ·Marine Drugs ·Nadège Loaëc,(unknown),Benoît Villiers,Émilie Durieu,Tania Tahtouh,(unknown),Rohan A. Davis,(unknown),Mélanie Roué,Marie‐Lise Bourguet‐Kondracki,Peter Proksch,Emmanuelle Limanton,Solène Guihéneuf,François Carreaux,Jean Pierre Bazureau,Michelle Klautau,Laurent Meijer	42
8	From Drug Screening to Target Deconvolution: a Target-Based Drug Discovery Pipeline Using Leishmania Casein Kinase 1 Isoform 2 To Identify Compounds with Antileishmanial Activity 2016 ·Antimicrobial Agents and Chemotherapy ·Émilie Durieu,Eric Prina,L Olivier,Nassima Oumata,Nicolas Gaboriaud‐Kolar,Konstantina Vougogiannopoulou,Nathalie Aulner,(unknown),Joo Hwan No,(unknown),Alexios‐Léandros Skaltsounis,Hervé Galons,Gérald F. Späth,Laurent Meijer,Najma Rachidi	41
9	New 5-ylidene rhodanine derivatives based on the dispacamide A model 2014 ·Molecular Diversity ·Solène Guihéneuf,Ludovic Paquin,François Carreaux,Émilie Durieu,Thierry Roisnel,Laurent Meijer,Jean Pierre Bazureau	16
10	Exploring the Synthesis of New 1-(4-Substitutedphenylamino) imidazo[1,5-a]indol-3-one Derivatives as Cyclized Analogs of Leucettines 2014 ·Journal of Applied Pharmaceutical Science ·(unknown),Emmanuelle Limanton,François Carreaux,Émilie Durieu,Laurent Meijer,Jean Pierre Bazureau	3
11	Dispacamide E and other bioactive bromopyrrole alkaloids from two Indonesian marine sponges of the genus Stylissa 2014 ·Natural Product Research ·Sherif S. Ebada,(unknown),Arlette Longeon,Nicole J. de Voogd,Émilie Durieu,Laurent Meijer,Marie‐Lise Bourguet‐Kondracki,Abdel Nasser B. Singab,Wernér E.G. Müller,Peter Proksch	33
12	Inhibition of NF-κB–Mediated Signaling by the Cyclin-Dependent Kinase Inhibitor CR8 Overcomes Prosurvival Stimuli to Induce Apoptosis in Chronic Lymphocytic Leukemia Cells 2013 ·Clinical Cancer Research ·Emilio Cosimo,Alison M. McCaig,(unknown),Helen Wheadon,(unknown),(unknown),Christian Berthou,Émilie Durieu,Nassima Oumata,Hervé Galons,Laurent Meijer,Alison M. Michie	28
13	cdc-Like/Dual-Specificity Tyrosine Phosphorylation–Regulated Kinases Inhibitor Leucettine L41 Induces mTOR-Dependent Autophagy: Implication for Alzheimer’s Disease 2013 ·Molecular Pharmacology ·(unknown),Émilie Durieu,Gaëtan Chicanne,Bernard Payrastre,Diego Sbrissa,Assia Shisheva,Emmanuelle Limanton,François Carreaux,Jean Pierre Bazureau,Laurent Meijer	26
14	Chemical synthesis and biological validation of immobilized protein kinase inhibitory Leucettines 2013 ·European Journal of Medicinal Chemistry ·(unknown),Tania Tahtouh,Émilie Durieu,(unknown),Emmanuelle Limanton,Laurent Meijer,François Carreaux,Jean Pierre Bazureau	23
15	Synthesis, Resolution, and Biological Evaluation of Atropisomeric (aR)- and (aS)-16-Methyllamellarins N: Unique Effects of the Axial Chirality on the Selectivity of Protein Kinases Inhibition 2013 ·Journal of Medicinal Chemistry ·(unknown),(unknown),(unknown),Junji Tanaka,Nadège Loaëc,Olivier Lozach,Émilie Durieu,Tsutomu Fukuda,Fumito Ishibashi,Laurent Meijer,Masatomo Iwao	57
16	Novel Inverse Binding Mode of Indirubin Derivatives Yields Improved Selectivity for DYRK Kinases 2012 ·ACS Medicinal Chemistry Letters ·Vassilios Myrianthopoulos,Marina Kritsanida,Nicolas Gaboriaud‐Kolar,Prokopios Magiatis,Yoan Ferandin,Émilie Durieu,Olivier Lozach,Daniel Cappel,M. Soundararajan,P. Filippakopoulos,Woody Sherman,Stefan Knapp,Laurent Meijer,Emmanuel Mikros,Alexios‐Léandros Skaltsounis	57
17	Synthesis of N,N′-bis(5-arylidene-4-oxo-3,5-dihydro-4H-imidazol-2-yl)diamines bearing various linkers and biological evaluation as potential inhibitors of kinases 2012 ·European Journal of Medicinal Chemistry ·(unknown),Ludovic Paquin,(unknown),Yves‐Alain Bekro,Émilie Durieu,Laurent Meijer,Jean Pierre Bazureau	11
18	An efficient approach to dispacamide A and its derivatives 2011 ·Organic & Biomolecular Chemistry ·Solène Guihéneuf,Ludovic Paquin,François Carreaux,Émilie Durieu,Laurent Meijer,Jean Pierre Bazureau	17
19	Synthesis, Protein Kinase Inhibitory Potencies, and in Vitro Antiproliferative Activities of Meridianin Derivatives 2011 ·Journal of Medicinal Chemistry ·F Giraud,Georges Alves,Eric Débiton,Lionel Nauton,Vincent Théry,Émilie Durieu,Yoan Ferandin,Olivier Lozach,Laurent Meijer,Fabrice Anizon,Elisabeth Pereira,Pascale Moreau	98
20	Identification and structure–activity relationship of 8-hydroxy-quinoline-7-carboxylic acid derivatives as inhibitors of Pim-1 kinase 2010 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),Émilie Durieu,Laurent Meijer,Jordi Rodrigo,Didier Desmaële	35

About Émilie Durieu

Émilie Durieu is a scholar working on Toxicology, Biotechnology and Physiology, having authored 26 papers that have together received 874 indexed citations. Recurring topics across this work include Synthesis and biological activity (6 papers), Synthesis and Characterization of Heterocyclic Compounds (3 papers) and Microbial Natural Products and Biosynthesis (3 papers). The work is most often cited by research in Organic Chemistry (313 citations), Toxicology (31 citations) and Biotechnology (67 citations). Émilie Durieu has collaborated with scholars based in France, United Kingdom and United States. Frequent co-authors include Laurent Meijer, Jean Pierre Bazureau, François Carreaux, Olivier Lozach, Tania Tahtouh, Stefan Knapp, P. Filippakopoulos, M. Soundararajan, Yoan Ferandin and Ralf S. Schmid. Their work appears in journals such as Clinical Cancer Research, The FASEB Journal and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact